Evidence map›Paper›PMID 41140907›Full record

ArticleOphthalmology science2026

Associations between Progression of Retinal Pigment Epithelial and Outer Retinal Atrophy and Choroidal Thickness: A 2-Year observation.

Norihiro Nagai, Hajime Shinoda, Hisashi Matsubara, Hiroto Terasaki, Takao Hirano, Aki Kato, Akiko Miki, Hiromasa Hirai, Fumiko Murao, Hiroko Imaizumi and 9 more

Abstract read
In one paragraph

Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Tomographic phenotypes and conditional time to atrophic conversion in dry age-related macular degeneration among progressors: an interval-censored study.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Norihiro NagaiDepartment of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
Hajime ShinodaDepartment of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
Hisashi MatsubaraDepartment of Ophthalmology, Mie University Graduate School of Medicine, Tsu, Japan.
Hiroto TerasakiDepartment of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Science, Kagoshima, Japan.
Takao HiranoDepartment of Ophthalmology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Aki KatoDepartment of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Akiko MikiDivision of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Hiromasa HiraiDepartment of Ophthalmology, Nara Medical University, Nara, Japan.
Fumiko MuraoDepartment of Ophthalmology, Tokushima University Graduate School, Tokushima, Japan.
Hiroko ImaizumiDepartment of Ophthalmology, Sapporo City General Hospital, Sapporo, Japan.
Fumi GomiDepartment of Ophthalmology, Hyogo Medical University, Nishinomiya, Japan.
Yoshinori MitamuraDepartment of Ophthalmology, Tokushima University Graduate School, Tokushima, Japan.
Nahoko OgataDepartment of Ophthalmology, Nara Medical University, Nara, Japan.
Sentaro KusuharaDivision of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Tsutomu YasukawaDepartment of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Toshinori MurataDepartment of Ophthalmology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Taiji SakamotoDepartment of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Science, Kagoshima, Japan.
Mineo KondoDepartment of Ophthalmology, Mie University Graduate School of Medicine, Tsu, Japan.
Yoko OzawaDepartment of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate the clinical course of retinal pigment epithelial and outer retinal atrophy (RORA) with best-corrected visual acuity (BCVA) and risk factors for rapid progression to explore the pathogenesis. Design: Retrospective observational study. Subjects: Data on eyes with fovea-involved RORA associated with age-related macular degeneration were collected over time from 10 hospitals in Japan. Methods: Data on ophthalmic examination, BCVA, and OCT images were analyzed. Main Outcome Measures: Relationships between changes in BCVA and extents of RORA and outer plexiform layer (OPL) deterioration and their associations with central choroidal thickness (CCT) and pachychoroid characteristics at baseline were evaluated. Results: Of the 53 eyes of 53 patients (mean age; 74.9 ± 1.4 years), 32 eyes (60.4%) belonged to men. The progression in the mean extent of OPL deterioration was evident at year 1, whereas that of RORA, BCVA impairment, thinning of the central retinal thickness, and CCT became apparent at year 2 ( Conclusions: The change in BCVA paralleled the changes in the extents of RORA and OPL deterioration. Rapid BCVA impairment was observed in eyes with longer RORA at baseline. A thinner choroid, SDD, and drusen were risk factors, and pachychoroid characteristics were protective factors against RORA progression. Further studies are warranted to better understand the progression of RORA and vision loss. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Age-related macular degenerationChoroidal thicknessGeographic atrophyPhotoreceptorRetinal pigment epithelium.

Identifiers

PMID41140907
PMCPMC12550781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.